PRPO Precipio, Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1043961 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY21.8%
TTM net income YoY8.8%
TTM EPS YoY27.2%
Revenue 3-yr CAGR27.9%
Net income 3-yr CAGR—
Margins
Gross margin44.6%
Operating margin-5.3%
Net margin-4.1%
FCF margin5.0%
EBITDA margin-1.1%
Returns
ROE-8.0%
ROA-5.3%
ROIC (approx.)-10.1%
Asset turnover1.30x
Leverage & solvency
Liabilities / assets31.5%
Debt / equity0.02x
Current ratio1.77x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.49x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $24.05M | $18.53M | $15.20M | $9.41M | $8.85M |
| Cost of revenue | $13.34M | $10.97M | $9.18M | $6.90M | $6.46M |
| Gross profit | $10.71M | $7.56M | $6.02M | $2.51M | $2.39M |
| R&D expense | $1.60M | $1.30M | $1.70M | $1.70M | $1.30M |
| Operating income | -$1.20M | -$4.22M | -$7.62M | -$12.80M | -$9.61M |
| Pretax income | -$363,000 | -$4.29M | -$5.85M | -$12.18M | -$8.52M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$363,000 | -$4.29M | -$5.85M | -$12.20M | -$8.53M |
| EBITDA | $43,000 | -$3.02M | -$6.39M | -$11.58M | -$8.48M |
| EPS (basic) | -0.23 | -2.93 | -4.51 | -10.73 | -0.40 |
| EPS (diluted) | -0.23 | -2.93 | -4.51 | -10.73 | -0.40 |
| Weighted avg. shares (diluted) | 1.61M | 1.47M | 1.30M | 1.14M | 21.10M |
| Balance sheet | |||||
| Cash & equivalents | $2.65M | $1.39M | $1.50M | $3.44M | $11.67M |
| Receivables | $1.98M | $799,000 | $1.30M | $1.04M | $697,000 |
| Inventory | $935,000 | $724,000 | $384,000 | $708,000 | $564,000 |
| Current assets | $6.04M | $3.45M | $3.68M | $5.71M | $13.48M |
| PP&E, net | $729,000 | $719,000 | $739,000 | $877,000 | $836,000 |
| Intangibles | $10.92M | $11.87M | $12.82M | $13.77M | $14.72M |
| Total assets | $21.32M | $17.00M | $18.10M | $21.50M | $30.44M |
| Current liabilities | $3.75M | $4.27M | $3.14M | $4.36M | $4.21M |
| Short-term debt | $30,000 | $297,000 | $235,000 | $255,000 | $26,000 |
| Long-term debt | $47,000 | $77,000 | $106,000 | $134,000 | $160,000 |
| Total debt | $77,000 | $374,000 | $341,000 | $389,000 | $186,000 |
| Total liabilities | $6.76M | $4.90M | $3.67M | $5.14M | $5.83M |
| Shareholders' equity | $14.56M | $12.09M | $14.43M | $16.30M | $24.56M |
| Net debt | -$2.57M | -$1.01M | -$1.16M | -$3.06M | -$11.48M |
| Shares outstanding | 1.78M | 1.49M | 1.42M | 1.14M | 22.71M |
| Cash flow statement | |||||
| Operating cash flow | $685,000 | $439,000 | -$3.56M | -$7.72M | -$6.58M |
| Capital expenditure | $326,000 | $223,000 | $126,000 | $277,000 | $682,000 |
| Free cash flow | $359,000 | $216,000 | -$3.69M | -$8.00M | -$7.26M |
| Investing cash flow | -$326,000 | -$223,000 | -$126,000 | -$277,000 | -$682,000 |
| Financing cash flow | $903,000 | -$329,000 | $1.74M | -$225,000 | $16.27M |
| Depreciation & amortization | $1.25M | $1.20M | $1.23M | $1.22M | $1.13M |
| Stock-based compensation | $1.21M | $1.49M | $1.56M | $3.80M | $1.88M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.